No Data
No Data
Mizuho Securities Initiates Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $51
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Mizuho Initiates Coverage On Tectonic Therapeutic With Outperform Rating, Announces Price Target of $51
Express News | Tectonic Therapeutic to Present Phase 1B Data for Tx45 at European Society of Cardiology Heart Failure 2025
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
Tectonic Therapeutic Insider Bought Shares Worth $2,299,015, According to a Recent SEC Filing